Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease
Authors:
Open Access
- 1 April 2018
- journal article
- editorial
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 3 (2) , 210-212
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- High-Density LipoproteinCirculation Research, 2014
- Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complexJournal of Clinical Investigation, 2013
- Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2Immunity, 2013
- Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery DiseaseCirculation, 2013
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary SyndromeNew England Journal of Medicine, 2012
- Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery diseaseJournal of Clinical Investigation, 2011
- RVX-208JACC, 2010
- Age-related impairment of HDL-mediated cholesterol effluxJournal of Lipid Research, 2007
- Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.Journal of Clinical Investigation, 1990
- Incidence of Coronary Heart Disease and Lipoprotein Cholesterol LevelsJAMA, 1986